A Psychoeducation Intervention for Caregivers of Patients With Bipolar Disorder
1 other identifier
interventional
12
1 country
1
Brief Summary
Bipolar disorder is a debilitating chronic illness characterized by periods of elation and depression. Since deinstitutionalization of the mentally ill over 40 years ago, families have become major caregivers for patients with bipolar disorder . This illness imposes a substantial and chronic burden on family caregivers Despite their persistent stress and burden, these caregivers have been largely ignored. Interventions to help them have been very limited. One comprehensive intervention was developed and implemented by Miklowitz (2008) and has shown to be effective in reducing caregiver depression and improving health outcomes. However, this intervention and is highly complex, long, and was given on an individual basis, significantly raising the cost of the program. One core component of the Miklowitz (2008) intervention is psychoeducation, which provides the fundamental support and information needed to caregivers on an individual basis. In this pilot study, the intervention group will receive 7 weekly psychoeducation sessions. After completion of these sessions in the intervention group, the wait list control group will receive the same weekly sessions. In this study, the investigators plan to test the feasibility and potential efficacy of this specific psychoeducation intervention implemented in a group setting. The investigators will also examine the effects of this psychosocial intervention on biological mechanisms (cortisol and inflammatory biomarkers) and health outcomes. The specific aims are to:
- 1.Test the feasibility of implementing a 7-week group psychoeducation program for family caregivers of patients with bipolar disorder by assessing recruitment and retention rates, attendance, satisfaction with the program, and data and sample collection rate.
- 2.Explore the effect of the intervention on caregiver outcomes (depression, burden, health status, mental wellbeing, cortisol, interleukin (IL)-1 and IL-6 levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 23, 2015
CompletedFirst Posted
Study publicly available on registry
May 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedNovember 3, 2020
November 1, 2020
6.2 years
April 23, 2015
November 2, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Caregiver Burden as measured by the Burden Assessment Scale at 8 weeks
Baseline, 8 weeks
Change in Caregiver Burden as measured by the Burden Assessment Scale at 16 weeks
Baseline, 16 weeks
Secondary Outcomes (4)
Change in Caregiver Mental Well Being as measured by the Warwick-Edinburgh Mental Well-Being Scale at 8 weeks
Baseline, 8 weeks
Change in Caregiver Mental Well Being as measured by the Warwick-Edinburgh Mental Well-Being Scale at 16 weeks
Baseline, 16 weeks
Change in Caregiver Depression as measured by the Quick Inventory of Depressive Symptomatology Clinician-Rated at 8 weeks
Baseline, 8 weeks
Change in Caregiver Depression as measured by the Quick Inventory of Depressive Symptomatology Clinician-Rated at 16 weeks
Baseline, 16 weeks
Study Arms (2)
Experimental Group
EXPERIMENTALThe experimental group will receive a 7-week group psychoeducation intervention. Caregivers will meet once a week for 90-minute sessions in a group setting. Dates and times of the group sessions will be arranged according to the convenience of the subjects. The major content will include the causes of bipolar disorder, signs and symptoms of bipolar disorder, the role of stress and life events, types of medications and what they do, self-management of the disorder, understanding the course of the disorder, genetic and biological predispositions, how the family can help, management of relapse.
Wait List Control Group
ACTIVE COMPARATORSubjects in the wait list control group will receive the same 7 psychoeducation sessions after the experimental group receives these sessions.
Interventions
Caregivers will meet once a week for 90-minute sessions in a group setting. Dates and times of the group sessions will be arranged according to the convenience of the subjects. The major content will include the causes of bipolar disorder, signs and symptoms of bipolar disorder, the role of stress and life events, types of medications and what they do, self-management of the disorder, understanding the course of the disorder, genetic and biological predispositions, how the family can help, management of relapse.
The wait list control group will receive the same intervention as the experimental group, but 7 weeks later.
Eligibility Criteria
You may qualify if:
- primary family caregiver of a patient with Bipolar Disorder who is age 16 or older;
- live within a 70 mile radius of the Center for Excellence in Mood Disorders (in the Texas Medical Center)
You may not qualify if:
- unstable major medical illness;
- health condition that may impact biomarker levels, e.g. is taking corticosteroids or anti-inflammatory drugs;
- unable to read, write, or speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas Health Science Center at Houston School of Nursing
Houston, Texas, 77070, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor - Clinical
Study Record Dates
First Submitted
April 23, 2015
First Posted
May 18, 2015
Study Start
September 1, 2013
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
November 3, 2020
Record last verified: 2020-11